Cargando…

Thromboangiitis obliterans: Aggressive angioplasty provides a potential solution (randomized pilot study)

BACKGROUND: Thromboangiitis obliterans is an inflammatory disease affecting both medium- and small-sized vessels. Vasodilators, antiplatelets were proposed for treatment but the effect was minimal. OBJECTIVE: This study was conducted to investigate the effect of balloon angioplasty on patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Soliman, Mosaad, Mowafy, Khaled, Elsaadany, NA, Soliman, Reem, Elmetwally, Ahmed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7278296/
https://www.ncbi.nlm.nih.gov/pubmed/32551111
http://dx.doi.org/10.1177/2050312120927636
_version_ 1783543305797107712
author Soliman, Mosaad
Mowafy, Khaled
Elsaadany, NA
Soliman, Reem
Elmetwally, Ahmed
author_facet Soliman, Mosaad
Mowafy, Khaled
Elsaadany, NA
Soliman, Reem
Elmetwally, Ahmed
author_sort Soliman, Mosaad
collection PubMed
description BACKGROUND: Thromboangiitis obliterans is an inflammatory disease affecting both medium- and small-sized vessels. Vasodilators, antiplatelets were proposed for treatment but the effect was minimal. OBJECTIVE: This study was conducted to investigate the effect of balloon angioplasty on patients with Buerger’s disease compared to medical treatment. METHODS: Between January 2006 and December 2016, 82 patients with Buerger’s disease were enrolled in the study, of whom 52 were randomized to the aggressive endovascular intervention and 30 were randomized medically by cilostazol and aspirin as a control group. In all, 23% of the patients presented with severe claudication, 50% with ischemic rest pain and 27% with ischemic ulcers. Randomization was done using the opaque envelope method. Allocation concealment was maintained to ensure no selection bias. Patient groups were compared for the duration of ulcer healing, ankle–brachial index, peak systolic velocity changes and transcutaneous oximetry (TcPO2) level for 30 months. RESULTS: No major procedural complications occurred in the endovascular group. Angiographic success was achieved in 100% of supragenicular lesions but in 90% of infrapopliteal lesions. The endovascular group showed a statistically significant improvement in the ulcer healing size and duration at 6 months after the procedure with a mean time of 3 ± 0.9 months compared to 5.8 ± 1.69 months for the medical treatment group (p < 0.001), the mean TcPO2 from 27.23 ± 16.75 mm Hg (range: 0–56 mm Hg) before the procedure to 71.32 ± 12.94 mm Hg (range: 52–92 mm Hg) following revascularization (p < 0.01). The mean ankle–brachial index significantly improved from 0.54 ± 0.14 preoperatively to 0.82 ± 0.08 at final follow-up (p < 0.01). CONCLUSION: The endovascular therapy should be considered as an effective, safe, minimally invasive method in the light of the promising results after a modification of the standard technique.
format Online
Article
Text
id pubmed-7278296
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-72782962020-06-17 Thromboangiitis obliterans: Aggressive angioplasty provides a potential solution (randomized pilot study) Soliman, Mosaad Mowafy, Khaled Elsaadany, NA Soliman, Reem Elmetwally, Ahmed SAGE Open Med Original Article BACKGROUND: Thromboangiitis obliterans is an inflammatory disease affecting both medium- and small-sized vessels. Vasodilators, antiplatelets were proposed for treatment but the effect was minimal. OBJECTIVE: This study was conducted to investigate the effect of balloon angioplasty on patients with Buerger’s disease compared to medical treatment. METHODS: Between January 2006 and December 2016, 82 patients with Buerger’s disease were enrolled in the study, of whom 52 were randomized to the aggressive endovascular intervention and 30 were randomized medically by cilostazol and aspirin as a control group. In all, 23% of the patients presented with severe claudication, 50% with ischemic rest pain and 27% with ischemic ulcers. Randomization was done using the opaque envelope method. Allocation concealment was maintained to ensure no selection bias. Patient groups were compared for the duration of ulcer healing, ankle–brachial index, peak systolic velocity changes and transcutaneous oximetry (TcPO2) level for 30 months. RESULTS: No major procedural complications occurred in the endovascular group. Angiographic success was achieved in 100% of supragenicular lesions but in 90% of infrapopliteal lesions. The endovascular group showed a statistically significant improvement in the ulcer healing size and duration at 6 months after the procedure with a mean time of 3 ± 0.9 months compared to 5.8 ± 1.69 months for the medical treatment group (p < 0.001), the mean TcPO2 from 27.23 ± 16.75 mm Hg (range: 0–56 mm Hg) before the procedure to 71.32 ± 12.94 mm Hg (range: 52–92 mm Hg) following revascularization (p < 0.01). The mean ankle–brachial index significantly improved from 0.54 ± 0.14 preoperatively to 0.82 ± 0.08 at final follow-up (p < 0.01). CONCLUSION: The endovascular therapy should be considered as an effective, safe, minimally invasive method in the light of the promising results after a modification of the standard technique. SAGE Publications 2020-06-04 /pmc/articles/PMC7278296/ /pubmed/32551111 http://dx.doi.org/10.1177/2050312120927636 Text en © The Author(s) 2020 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Original Article
Soliman, Mosaad
Mowafy, Khaled
Elsaadany, NA
Soliman, Reem
Elmetwally, Ahmed
Thromboangiitis obliterans: Aggressive angioplasty provides a potential solution (randomized pilot study)
title Thromboangiitis obliterans: Aggressive angioplasty provides a potential solution (randomized pilot study)
title_full Thromboangiitis obliterans: Aggressive angioplasty provides a potential solution (randomized pilot study)
title_fullStr Thromboangiitis obliterans: Aggressive angioplasty provides a potential solution (randomized pilot study)
title_full_unstemmed Thromboangiitis obliterans: Aggressive angioplasty provides a potential solution (randomized pilot study)
title_short Thromboangiitis obliterans: Aggressive angioplasty provides a potential solution (randomized pilot study)
title_sort thromboangiitis obliterans: aggressive angioplasty provides a potential solution (randomized pilot study)
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7278296/
https://www.ncbi.nlm.nih.gov/pubmed/32551111
http://dx.doi.org/10.1177/2050312120927636
work_keys_str_mv AT solimanmosaad thromboangiitisobliteransaggressiveangioplastyprovidesapotentialsolutionrandomizedpilotstudy
AT mowafykhaled thromboangiitisobliteransaggressiveangioplastyprovidesapotentialsolutionrandomizedpilotstudy
AT elsaadanyna thromboangiitisobliteransaggressiveangioplastyprovidesapotentialsolutionrandomizedpilotstudy
AT solimanreem thromboangiitisobliteransaggressiveangioplastyprovidesapotentialsolutionrandomizedpilotstudy
AT elmetwallyahmed thromboangiitisobliteransaggressiveangioplastyprovidesapotentialsolutionrandomizedpilotstudy